Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanglian Jiedu Decoction is a classical traditional Chinese medicine formula composed of four herbs: Rhizoma coptidis (Huanglian), Radix scutellariae (Huangqin), Cortex phellodendri (Huangbo), and Fructus gardeniae (Zhizi) in a ratio of 3:2:2:3. It was first described in "Waitai Miyao" during the Tang dynasty and has been used for thousands of years in China as a heat-clearing and detoxifying agent. The main active components include berberine, baicalin, wogonoside, and gardenoside. It functions by clearing heat and detoxification, with each herb targeting different areas of the body: Huanglian reduces fire from the upper-jiao, Huangqin from the middle-jiao, Huangbo from the under-jiao, and Zhizi provides general heat clearing and detoxification. Modern research has identified several mechanisms of action including anti-inflammatory effects through reducing inflammatory factors (IL-6, TNF-α), antitumor activity, and neuroprotective effects. It has been studied for various conditions including multiple myeloma, Alzheimer's disease, type 2 diabetes, pneumonia, and inflammatory conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huanglian Jiedu Decoction.